These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 30217005)
1. Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model. Wang H; Feng T; Guo D; Zhang M; Chen L; Zhou Y Molecules; 2018 Sep; 23(9):. PubMed ID: 30217005 [TBL] [Abstract][Full Text] [Related]
2. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts. Zhai Y; Li Y; Wang Y; Cui J; Feng K; Kong X; Chen L Eur J Pharmacol; 2017 Apr; 801():62-71. PubMed ID: 28283388 [TBL] [Abstract][Full Text] [Related]
3. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157 [TBL] [Abstract][Full Text] [Related]
4. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296 [TBL] [Abstract][Full Text] [Related]
5. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway. Li L; Sapkota M; Gao M; Choi H; Soh Y Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027 [TBL] [Abstract][Full Text] [Related]
6. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
7. Leonurus sibiricus L. ethanol extract promotes osteoblast differentiation and inhibits osteoclast formation. Kim JH; Kim M; Jung HS; Sohn Y Int J Mol Med; 2019 Sep; 44(3):913-926. PubMed ID: 31524244 [TBL] [Abstract][Full Text] [Related]
8. Coenzyme q10 regulates osteoclast and osteoblast differentiation. Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186 [TBL] [Abstract][Full Text] [Related]
9. Antitumor agent cabozantinib decreases RANKL expression in osteoblastic cells and inhibits osteoclastogenesis and PTHrP-stimulated bone resorption. Stern PH; Alvares K J Cell Biochem; 2014 Nov; 115(11):2033-8. PubMed ID: 25042887 [TBL] [Abstract][Full Text] [Related]
10. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis. Yoshida T; Flegler A; Kozlov A; Stern PH J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676 [TBL] [Abstract][Full Text] [Related]
11. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation. Han SY; Lee KH; Kim YK Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250 [TBL] [Abstract][Full Text] [Related]
12. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Li F; Yang Y; Zhu P; Chen W; Qi D; Shi X; Zhang C; Yang Z; Li P Fitoterapia; 2012 Dec; 83(8):1443-50. PubMed ID: 22951288 [TBL] [Abstract][Full Text] [Related]
13. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts. Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547 [TBL] [Abstract][Full Text] [Related]
14. Onion ( Zhang D; Wang X; Sun K; Guo J; Zhao J; Dong Y; Bao Y Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928460 [TBL] [Abstract][Full Text] [Related]
15. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation. Park K; Ju WC; Yeo JH; Kim JY; Seo HS; Uchida Y; Cho Y Int J Mol Med; 2014 Jan; 33(1):178-84. PubMed ID: 24248634 [TBL] [Abstract][Full Text] [Related]
16. Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction. Wang L; Peng SY; Liu Y; Li P; Wang WJ Acta Pharmacol Sin; 2010 Apr; 31(4):470-5. PubMed ID: 20208552 [TBL] [Abstract][Full Text] [Related]
17. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice. Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791 [TBL] [Abstract][Full Text] [Related]
18. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673 [TBL] [Abstract][Full Text] [Related]
19. Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic. Zhang S; Feng P; Mo G; Li D; Li Y; Mo L; Yang Z; Liang D Biomed Pharmacother; 2017 Apr; 88():436-442. PubMed ID: 28122309 [TBL] [Abstract][Full Text] [Related]
20. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. Chen Z; Xue J; Shen T; Mu S; Fu Q Int J Mol Med; 2016 Feb; 37(2):329-38. PubMed ID: 26677102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]